- TV Footage
- Integrated Annual Reports
- Quarterly Reports
- Bayer Magazine
- BEENOW Magazine
- Farming’s Future Magazine
- research Magazine
- technology solutions Magazine
- From Molecules to Medicine
- From Molecules to Veterinary Medicines Brochure
- Integrated Weed Management
- Names | Figures | Facts
- Transfers of Value to Physicians Brochure
- Newsletter Overview
- Social Media
- Media Contact
Monheim, July 5, 2016 – With its open innovation program Grants4Traits, Bayer now supports novel ideas that will lead to innovative commercial seed products. Researchers at universities, other scientific institutions, or start-up companies all over the world working on traits that will help achieve higher yield, quality and safety in crops are encouraged to participate in Bayer’s new program.
Grants4Traits aims at finding novel proposals and promising technologies which could result in the development of innovative traits or approaches to provide yield enhancement, insect, weed and disease control in agricultural crops. This includes for instance solutions that protect crops from herbicides or decrease pressure from weeds; new approaches to optimize gene or protein expression, activity and regulation; or solutions to protect crops from insects, nematodes or fungal diseases.
Beyond funding promising projects, Bayer could also offer scientific assistance and develop further any research projects or ideas by providing its own expertise and technologies. This support could subsequently be extended into long-term research collaborations. Applications for Grants4Traits can be easily and quickly submitted via a website. Only non-confidential information should be submitted.
With its initiative, Bayer is seeking to drive innovation in seeds and traits. “Agriculture urgently needs new solutions. Crops worldwide are facing increasing pressure from weeds, insects, diseases and unfavorable climate conditions. We at Bayer see innovation as the main driver to solve this,” said Dr. Adrian Percy, Head of Research and Development at Bayer’s Crop Science Division. “Yet, this challenge is too big for one company alone. This is why big or small companies, universities and other research institutes need to join forces in order to sustain innovation and find the best solutions for sustainable agriculture together.”
Grants4Traits is the next open innovation project of Bayer’s Crop Science division after the successful launch of Grants4Targets, an initiative that aims to find new modes of action in crop protection, in February 2016. Since then, around 67 proposals have been submitted with Bayer supporting more than 20 projects of them.
Apply now for a grant and develop further some of your ideas towards products on http://grants4traits.bayer.com/
Submit your idea now! The next deadline is October 31st 2016.
A french version is available for download here
A spanish version is available for download here
A portuguese version is available for download here
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
Note to editors:
Print-quality photos can be downloaded from our website at www.news.bayer.com.
TV and multimedia editors can download or order updated film footage about Bayer free of charge at www.tv-footage.bayer.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.